Marksans Pharma has been de-registered from the purview of SICA and is no longer in Board for Industrial and Financial Reconstruction (BIFR) as per the directions of the BIFR in its hearing held on July 17, 2013. The summary record of proceedings of the hearing is awaited.
Marksans Pharma is engaged in production of prescription drugs, caters in areas like oncology, gastroenterology, antidiabetic, cardiovascular, pain management, gynaecology and others.